Marinus Pharma CS
(MRNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -98,722 | -74,497 | -38,669 | -141,405 | -99,636 |
| Depreciation Amortization | 1,516 | 627 | 254 | 205 | -169 |
| Other Working Capital | -9,709 | -8,235 | -5,575 | 2,169 | -7,770 |
| Other Operating Activity | 19,160 | 13,803 | 6,529 | 21,030 | 16,566 |
| Operating Cash Flow | $-87,755 | $-68,302 | $-37,461 | $-118,001 | $-91,009 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,885 | 29,885 | 20,885 | -28,495 | -34,995 |
| PPE Investments | -1,152 | -38 | N/A | -110 | -76 |
| Investing Cash Flow | $28,733 | $29,847 | $20,885 | $-28,605 | $-35,071 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -19,623 | -17,698 | N/A | N/A | -737 |
| Common Stock Issued | 257 | 257 | 257 | 26,627 | 26,703 |
| Financing Cash Flow | $-19,366 | $-17,441 | $257 | $26,627 | $25,966 |
| Beginning Cash Position | 120,572 | 120,572 | 120,572 | 240,551 | 240,551 |
| End Cash Position | 42,184 | 64,676 | 104,253 | 120,572 | 140,437 |
| Net Cash Flow | $-78,388 | $-55,896 | $-16,319 | $-119,979 | $-100,114 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,755 | -68,302 | -37,461 | -118,001 | -91,009 |
| Capital Expenditure | -1,152 | -38 | N/A | -119 | -85 |
| Free Cash Flow | -88,907 | -68,340 | -37,461 | -118,120 | -91,094 |